HL9: 5-[(3~{a}~{S},4~{S},6~{a}~{R})-2-oxidanylidene-1,3,3~{a},4,6,6~{a}-hexahydrothieno[3,4-d]imidazol-4-yl]-~{N}-(1-pyridin-4-ylpiperidin-4-yl)pentanamide
HL9 is a Ligand Of Interest in 6T1E designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 6T1E_HL9_A_405 | 97% | 38% | 0.077 | 0.99 | 1.14 | 1.27 | 3 | 4 | 0 | 0 | 100% | 1 |
| 6T31_HL9_A_201 | 99% | 55% | 0.058 | 0.99 | 0.51 | 1.2 | - | 5 | 0 | 0 | 100% | 1 |
| 6T1K_HL9_A_201 | 94% | 42% | 0.084 | 0.985 | 0.57 | 1.67 | - | 6 | 1 | 0 | 100% | 1 |
| 6T32_HL9_A_201 | 92% | 43% | 0.086 | 0.975 | 0.68 | 1.5 | - | 6 | 0 | 0 | 100% | 1 |
| 6T2L_HL9_A_201 | 89% | 54% | 0.108 | 0.988 | 0.6 | 1.15 | - | 6 | 0 | 0 | 100% | 1 |
| 6T2Z_HL9_B_201 | 88% | 54% | 0.098 | 0.972 | 0.58 | 1.2 | - | 4 | 0 | 0 | 100% | 1 |
